Una vez por día RELEXXII® (metilfenidato hidrocloruro de liberación prolongada) soporta el trastorno de hiperactividad de la atención (ADHD) Mes de conciencia
In the news release, Once-daily RELEXXII® (methylphenidate hydrochloride extended-release tablet) supports Attention Deficit Hyperactivity Disorder (ADHD) Awareness Month, issued 06-Oct-2026 by Alora Pharmaceuticals, LLC over PR Newswire, we are advised by the company that changes have...
Leer artículo original en All News Releases →